NYSE - Delayed Quote USD

Hinge Health, Inc. (HNGE)

114.32 -2.58 (-2.21%)

At close: October 30 at 4:00:02 PM EDT

113.50 -0.82 (-0.72%)

After hours: October 30 at 6:41:05 PM EDT

Trade HNGE on Coinbase

Chart Range Bar

Advanced Chart

AlphaSpace Chart

Loading chart for HNGE

Previous Close 116.90
Open 114.44
Bid 109.00 x 10000
Ask 117.00 x 10000
Day's Range 111.43 - 115.80
52 Week Range 30.08 - 117.55
Volume 2,878,659
Avg. Volume 1,906,518
Market Cap (intraday) 9.225B
Beta (5Y Monthly) --
PE Ratio (TTM) 37.73
EPS (TTM) 3.03
Earnings Date Nov 2, 2026
Forward Dividend & Yield -- (0.00%)
1y Target Est 114.31
Zacks Rating Neutral

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.

www.hingehealth.com

1,437

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Health Information Services

Industry

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

HNGE

146.11%

S&P 500 (^GSPC)

10.73%

1-Year Return

HNGE

134.94%

S&P 500 (^GSPC)

11.11%

3-Year Return

HNGE

189.42%

S&P 500 (^GSPC)

81.91%

5-Year Return

HNGE

189.42%

S&P 500 (^GSPC)

64.59%

Earnings Per Share

gaap GAAP

nongaap Normalized

gaap GAAP

nongaap Normalized

Revenue vs. Earnings

yearly Annual

quarterly Quarterly

yearly Annual

quarterly Quarterly

Q2 FY26

Revenue 212.82M

Earnings 43.13M

Profit Margin 20.27%

FY25

FY26

50M

100M

150M

200M

0.0%

5.0%

10.0%

15.0%

20.0%

Analyst Price Targets

90.00 Low

114.31 Average

114.32 Current

140.00 High

Analyst Recommendations

Strong Buy
Buy
Hold
Underperform
Sell

Latest Rating

Date 10/26/2026

Analyst Stifel

Rating Action Maintains

Rating Buy

Price Action Raises

Price Target 115 -> 130

Valuation Measures

  
  
 Annual 

Market Cap
Enterprise Value
Trailing P/E
Forward P/E
PEG Ratio (current)
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

Profit Margin

15.15%
Return on Assets (ttm)

7.70%
Return on Equity (ttm)

30.38%
Revenue (ttm)

720.06M
Net Income Avi to Common (ttm)

107.28M
Diluted EPS (ttm)

3.03

Balance Sheet and Cash Flow

Total Cash (mrq)

389.39M
Total Debt/Equity (mrq)

1.71%
Levered Free Cash Flow (ttm)

299.65M

MNTN MNTN, Inc.

9.35 -4.98%

OMDA Omada Health, Inc.

18.73 -4.68%

CHYM Chime Financial, Inc.

27.95 -3.19%

ETOR eToro Group Ltd.

22.51 -3.68%

MDLN Medline Inc.

32.12 +0.37%

U.S. markets closed

Hinge Health, Inc. (HNGE)

Trading disclosure

2.51%

17.56%

156.32%

146.11%

134.94%

189.42%

189.42%

Hinge Health, Inc. Overview Health Information Services / Healthcare

Full Time Employees

Fiscal Year Ends

Sector

Industry

Recent News

Performance Overview

YTD Return

1-Year Return

3-Year Return

5-Year Return

Earnings Trends

Earnings Per Share

Revenue vs. Earnings

Analyst Insights

Analyst Price Targets

Analyst Recommendations

Latest Rating

Statistics

Valuation Measures

Financial Highlights

Profitability and Income Statement

Balance Sheet and Cash Flow

Company Insights

Research Reports

People Also Watch